Andrea Stutz
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction to "Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor".
Journal: Journal of medicinal chemistry
Published: April 01, 2025
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor.
Journal: Journal of medicinal chemistry
Published: March 04, 2025
NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain.
Journal: The Journal of experimental medicine
Published: June 19, 2016
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
Journal: The Journal of allergy and clinical immunology
Published: April 08, 2016
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Journal: Nature medicine
Published: October 23, 2014
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation.
Journal: Nature immunology
Published: March 31, 2014
ASC speck formation as a readout for inflammasome activation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 16, 2013
Activation and regulation of the inflammasomes.
Journal: Nature reviews. Immunology
Published: May 25, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026